Older adults surpass vaccination goals during 2020-2021 flu season … Lighting upgrades in long-term care settings may significantly reduce fall rates … Animal therapy, technology 2 best ways to improve...
More news for Friday, March 24
By
Kimberly Bonvissuto
Mar 24, 2023
Benchmark, Springpoint, Lasell Village join Age-Friendly Employer list … County nursing home considers adding assisted living, worker housing to keep doors open … Master’s degree designed to meet...
More news for Friday, Jan. 27
By
Kimberly Bonvissuto
Jan 27, 2023
Headwinds may stall CCRC recovery, Fitch Ratings says … Turnover rates among assisted living staff hold steady for most operators: report … FDA advisory committee votes on proposed COVID-19 vaccine...
FDA advisers say next round of COVID-19 booster shots should target an XBB Variant
Jun 15, 2023
Protection against the original strain of the virus will be dropped from the updated vaccines as it could contribute to lower vaccine efficacy against newer strains.
Bivalent mRNA-1273.214 elicits better response against omicron
Sep 27, 2022
A booster dose of mRNA-1273.214 elicits more neutralizing antibodies against omicron compared with mRNA-1273, the original Moderna vaccine, with no new safety concerns.
COVID-19 vaccination linked to lower risk for postinfection outcomes
Mar 13, 2024
A reduced risk was seen for venous thromboembolism, arterial thrombosis/thromboembolism and heart failure.
Updated COVID-19 vaccine has effectiveness of 54 percent
Feb 06, 2024
Vaccine effectiveness was 49% at 60 to 119 days after vaccination among tests exhibiting spike gene target failure.
COVID-19 vaccine protection lasts at least six months after second dose
Feb 07, 2023
Vaccine effectiveness against death was lower for patients aged 80 years and older.
More news for Thursday, Dec. 22
By
Kimberly Bonvissuto
Dec 22, 2022
AHCA/NCAL has new handout: Why residents should get the bivalent booster … Senior living provider cannot sue state regulatory agency, court rules … Assisted living manager, elected official faces 19...
FDA approval of new COVID-19 boosters could come by Friday
Sep 07, 2023
The new booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating.